Child Neurology (Pediatric Neurology) — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: child neurology, peds neuro. Own residency track (its own NRMP Match category) entered from medical school, rather than a fellowship of adult neurology. Organ system: the developing nervous system, meaning brain, spinal cord, nerve, and muscle in children.

The 30-second version

Child neurology is the specialty of the developing nervous system, the doctors who work up the child's first seizure, follow a family through years of epilepsy or muscular dystrophy, and, increasingly, hand parents a gene therapy for a disease that used to be a death sentence. It sits at the crossroads of pediatrics, neuroscience, and genetics: heavy on diagnostic reasoning, built on multi-year relationships with kids and families, and, right now, in the middle of a genuine therapeutic renaissance. It's also one of the lowest-paid fields in medicine and carries real emotional weight, because much of the disease is severe, genetic, or degenerative. The defining trade is this: you accept peds-adjacent pay and a long training path in exchange for enormous meaning, near-total job security from a severe national shortage, and a front-row seat as once-untreatable diseases become treatable.

Quick dashboard (details and sources below)
Training after med school 5 years (2 yrs pediatrics + 3 yrs neurology, incl. ~1 yr adult neuro)
Total from college start ~13 years (4 undergrad + 4 med school + 5 residency)
Competitiveness Low — positions go unfilled every year ⟳
Typical full-time pay ~$290,000–$335,000 total comp ⟳
Pay range (structure) 10th pct ~$260k · median ~$335k · 90th pct ~$395k (SalaryDr panel, n=23) ⟳
Lifestyle Largely daytime clinic + inpatient blocks; phone-heavy call; ~45 hrs/wk
Burnout Parent neurology 44% (Medscape 2024), on the low side of that table; no survey measures child neurology separately ⟳
% women Majority-women field; 64.9% of residents (AY2024-25), 56% of faculty ⟳
DO / IMG accessibility Below the all-PGY-1 averages on both counts — 13.7% DO against 21.5%, 18.5% IMG against 25.2% (2026, positions filled); IMG rising, DO volatile (17.3% in 2025) ⟳

What they actually do

Child neurologists diagnose and treat disorders of the developing brain, spinal cord, nerve, and muscle in children, a moving target that adult neurology doesn't have, because the substrate itself is still forming. The bread-and-butter is epilepsy (the single largest slice), plus headache/migraine, developmental delay and autism, cerebral palsy, neuromuscular disease, movement disorders, pediatric stroke, neuroinflammatory disease, and the genetic/metabolic and neurodegenerative conditions that make the field a de facto part-time genetics practice. The core skill is diagnostic reasoning over long arcs: localizing a lesion in a child who can't give a history, interpreting an EEG or a genetic variant, and then managing, often for years, conditions that can't always be cured.1

The work has a dual identity. Most of it is outpatient continuity clinic, the source of the field's signature multi-year relationships with kids and families (epilepsy, headache, developmental, neuromuscular, movement follow-up). The rest is inpatient consults at children's hospitals: the ED, the floor, and especially the NICU/PICU, where neonatal seizures, hypoxic-ischemic encephalopathy, brain injury, and neuromuscular emergencies live. Many child neurologists split their time or rotate onto service in blocks.1

Representative work: clinical neurologic and developmental exams in kids · EEG interpretation and long-term/continuous EEG monitoring (EMU) · epilepsy-surgery work-ups · lumbar puncture · management of status epilepticus and refractory seizures · genetic testing and variant interpretation · administering and managing disease-modifying and gene therapies (e.g., for SMA) · neonatal neuro consults and cEEG in the NICU. Compared with procedural specialties, child neurology is cognitive and diagnostic rather than procedure-dense.12

A day in the life: A clinic day is largely daytime and predictable, a mix of new consults (a first seizure, a developmental concern, headaches) and long-term follow-ups you've known for years. An inpatient service week looks different: consults from the ED and floor, NICU/PICU questions, and a lot of EEG review. Call is driven by acute neurologic emergencies such as status epilepticus, new-onset epilepsy, neonatal seizures, and HIE, but is often phone-heavy from home with tele-EEG review rather than middle-of-the-night procedures. How brutal call is depends almost entirely on group size: large academic centers spread it thin; solo or small groups in underserved areas can carry a punishing load.1

The training path & time to completion

Child neurology is its own board-certified specialty with its own Match category, rather than a fellowship of adult neurology. You match into it (or into a paired pediatrics + child-neuro program) straight out of medical school, and it's a 5-year (60-month) pathway accredited by ACGME and boarded by ABPN.34

The standard 5-year structure:34

  • 2 years of general pediatrics at the front (one required year plus, most commonly, a second peds year; see the 5th-year options below).
  • 3 years (36 months) of child neurology residency, which itself includes roughly 12 months of adult and general neurology, which is why child neurologists are trained across the age spectrum and understand the adult trajectory of pediatric-onset disease.
  • The 5th year is satisfied by one of four ABPN-approved options: (1) a second full year of general pediatrics (the most common route, since two peds years also make you eligible for American Board of Pediatrics certification); (2) ≥6 months of internal medicine plus additional approved months; (3) one year of ACGME family medicine; or (4) one year of basic neuroscience research (needs individual ABPN pre-approval ~6 months out).

Match routes (NRMP): you can match into (a) a combined 5-year "reserved" pediatrics/child-neurology program as one unit; (b) a categorical child neurology position paired with a preliminary pediatrics year; or (c) via separate rank lists. A dedicated research track (1 yr peds + 1 yr adult neuro + 2 yr clinical child neuro + 1 yr basic neuroscience) exists for academic careers.5

Boards: the primary board is ABPN, which certifies "Neurology with Special Qualification in Child Neurology." Many trainees also earn ABP (American Board of Pediatrics) certification: with ≥2 accredited peds years meeting ABP requirements (and being designated on the ABP portal by ~9 months into the R-1 year), you can sit for both general pediatrics and child neurology boards.46

  • Program footprint: 83 ACGME-accredited child neurology programs and 498 active residents in academic year 2024–25, so roughly six residents per program.7
  • Total from the start of college: ~13 years (4 undergrad + 4 med school + 5 residency). Add 1–2 years for a fellowship (epilepsy, neuromuscular, and so on), none of which is required to practice.

How competitive is it?

Child neurology is one of the more accessible paths in medicine to a highly specialized career, and the reason is a documented national workforce shortage that leaves positions unfilled most years.

  • 2025 Match (PGY-1): 78 programs · 195 positions · 185 filled · 10 unfilled · 94.9% fill rate. Of the 185 filled: US MD ~63.8%, DO 17.3%, IMG (US + non-US) 17.8%.8 ⟳
  • 2024 Match (PGY-1): 79 programs · 184 positions · 177 filled · 7 unfilled · 96.2% fill rate. Of the 177 filled: US MD ~75.1%, DO 12.4%, IMG 11.9%.9 ⟳
  • The revealing number: in 2025 only 136 US-MD seniors ranked child neurology for 195 positions, so there were more positions than committed US-senior applicants, the signature of a shortage specialty.8 ⟳
  • 2026 Match (PGY-1): 83 programs · 211 positions · 205 filled · 6 unfilled · 97.2% fill rate, with positions up ~27% since 2022 (166 then, 211 now), so the pipeline is expanding as demand climbs. Of the 205 filled: US MD 67.8%, DO 13.7%, IMG 18.5%.10 ⟳

Secondary sources rate child neurology "Low" competitiveness for US seniors and IMG-friendly given the roughly 1:1 applicant-to-position environment.11 Matched-applicant academics (2022 cycle, as summarized from NRMP Charting Outcomes) run mean Step 2 CK ~247, with an unusually high share of PhDs (>21% of matched applicants, among the highest of any specialty), reflecting how research-heavy the academic side of the field is.12 ⟳

The three-year trend has two halves. Positions keep growing (184 → 195 → 211) and the IMG share keeps rising (11.9% → 17.8% → 18.5%), so child neurology is genuinely opening up to international graduates. The DO share is volatile rather than rising: 12.4% in 2024, 17.3% in 2025, then 13.7% in 2026, which gives back most of the 2025 gain. Read DO access as a band of roughly 12–17% rather than as a trend line.8910 The honest read: this is reachable for a solid, well-rounded applicant in a way the most competitive fields never are, but the same unfilled-positions dynamic is a direct signal about the pay and workforce realities you'd graduate into.

Compensation — the robust version

Child neurology is one of the lowest-paid physician specialties, and the framing that matters most is a three-way comparison: it pays slightly above general pediatrics but well below adult neurology. A note on sources first: the surveys disagree because they measure different things (large self-reported samples vs. recruiter/placement benchmarks vs. paywalled employer data). Treat Doximity as the anchor for cross-specialty positioning, SalaryDr, a self-selected panel of 23, as the best current guide to spread, and AMN as a floor-ish placement/base view.131415

The headline positioning (Doximity 2025, 2024 data): Adult Neurology $360,519 · Child Neurology $289,738 · General Pediatrics $265,230. Child neurology pays roughly $25k more than general pediatrics (+9%) but roughly $71k less than adult neurology (−20%), despite comparable or longer training and comparable case complexity. Doximity itself frames this as a "systemic lag in pay for pediatric specialty care."13 ⟳

A defensible "typical" number. Because self-reported surveys run higher than Doximity, a realistic central band for 2025–26 total compensation is ~$290k (Doximity) to ~$335k (SalaryDr median), trending up.1314 ⟳

The spread (structure, from SalaryDr 2026): 10th pct $260,000 · 25th pct $279,790 · median $335,000 · mean $329,273 · 75th pct $345,000 · 90th pct $395,000; observed overall range $260,000–$500,000. Base salary is ~$270,839 (~82% of total), and 96% receive a bonus (median $65,000, IQR $30k–$75k). Those percentiles rest on about 23 verified submissions, a small enough sample to read them as indicative rather than settled.14 ⟳

The recruiter/placement floor (AMN 2025). AMN quotes pediatric/child neurology at $225,000–$250,000 with starting ~$180,000 base, lower than total-comp surveys because it's a placement and base-oriented figure. For context in the same report: adult neurology avg $244,000, neuro-oncology $341,000, MS $267,000, movement disorders $240,000.15 ⟳

MGMA publishes pediatric neurology median comp and wRVU benchmarks in its annual Provider Compensation and Productivity Data Report (2025 edition, 2024 data), but the specialty dollar figures sit behind a paywall.16

Seniority barely moves the needle, and the curve is flat. SalaryDr: early career (0–5 yrs) $305,229 against 10+ years $347,769, only about a 14% lifetime increase, notably flatter than procedural specialties. The same page also publishes finer experience buckets that run from $260,000 at 0–2 years to $396,667 at 16+, a far steeper span assembled from three submissions per cell, so treat the flat headline as the more stable of the two cuts rather than as a settled shape.14 ⟳

Setting: academic pays less than hospital-employed. Child neurology is predominantly academic and children's-hospital-employed, because most subspecialty volume (EEG, epilepsy monitoring units, complex genetic/neuromuscular disease, neonatal neuro) lives in tertiary children's hospitals, and pure private child-neuro practice is comparatively uncommon. SalaryDr (2026, small samples): hospital-employed ~$340,486 against academic ~$308,714, roughly a $32k academic discount, traded for teaching, protected research time, and access to NIH loan-repayment-eligible research funding.14 ⟳

Geography, and a shortage-driven inversion. SalaryDr city averages (2026, small self-reported samples) skew toward large academic/children's-hospital metros: Los Angeles ~$380k · Boston ~$370k · Miami ~$360k · Chicago ~$350k · Houston ~$340k, and these cluster above the national median partly because the field is concentrated in big academic markets.14 ⟳ But the usual "rural pays less" rule is inverted here by scarcity: because supply outside cities is so thin (see below), rural/underserved markets increasingly compete with recruitment premiums, signing bonuses, and loan-repayment incentives rather than a rural discount.17

Employment models. Academic medical center / children's-hospital employment is dominant (salary + modest wRVU incentive + protected research/teaching time + NIH LRP eligibility); health-system/hospital employment (salary + wRVU bonus) is the highest-paying model in SalaryDr's sample; private group and solo practice is least common, and more feasible in general child neuro like headache and epilepsy follow-up than in high-acuity subspecialties; and locum tenens / telehealth is growing fast as a shortage-mitigation model (tele-EEG, tele-consults, Project ECHO hub-and-spoke).1417

The trend that colors all of it. High-cost gene and disease-modifying therapies (see Fun facts) are raising child neurology's institutional value and visibility faster than its base pay. The persistent "pediatric pay gap," where pediatric care is disproportionately Medicaid-reimbursed and cognitive rather than procedural, remains the dominant story. Commentators consistently name reimbursement reform, not market demand, as the lever most likely to close the gap.1318 ⟳

Lifestyle & the trade

For such a highly specialized field, child neurology is relatively controllable, one of the more family-friendly ways to do subspecialty medicine, and a real part of its draw.19

  • Hours: ~45 hrs/week is a common self-reported average, moderate for a physician specialty. Academic/tertiary and inpatient-heavy jobs skew longer; outpatient-only community roles run lighter. EHR/administrative burden is real (neurologists broadly report ~17+ documentation hours/week).1419
  • Call: driven by acute neurologic emergencies: status epilepticus, new-onset epilepsy work-ups, and NICU and PICU consults for neonatal seizures, HIE, and brain injury. Continuous EEG monitoring generates overnight questions, but call is often phone-heavy from home with tele-EEG review rather than in-house procedures. Frequency depends heavily on group size, and this is the single biggest lifestyle variable.19
  • Schedule control: moderate-to-good relative to acute-care specialties. Clinic practice is largely predictable and daytime; variability comes from inpatient service weeks and call. Telehealth works well for follow-ups (helpful given the geographic shortage), and demand gives child neurologists strong leverage over their own schedules. Outpatient-only, no-inpatient arrangements exist and are a real lifestyle lever.19

Lifestyle rating: 4/5. Largely daytime, continuity-based, and controllable, with the main caveats being inpatient service weeks, phone-heavy call around neurologic emergencies, and heavy documentation.

Wellbeing — the part to take seriously

The parent field's burnout is mid-table, and nothing measures child neurology on its own. Neurology runs 44% on Medscape's 2024 report, on the low side of the twenty specialties that table names, against a 49% all-physician average. What exists for child neurology specifically is commentary rather than a survey: a 2026 op-ed puts burnout symptoms north of 80% in the field and names no instrument behind the figure. The named drivers: the workforce shortage → overbooked clinics and long waitlists, documentation and prior-authorization burden, moral distress from untreatable/degenerative disease, and pay perceived as low for the length of training.201819 ⟳

Satisfaction and would-choose-again, the counterweight. Despite that load, satisfaction is notably high: self-reported job satisfaction ~4.0/5 and "would choose the specialty again" ~87% (SalaryDr 2026). This "high burnout, high meaning" pattern is characteristic: draining but deeply worthwhile.14 ⟳

The emotional weight (the defining feature). Child neurologists routinely care for children with severe, progressive, degenerative, and genetic neurologic disease, some of it fatal and much of it lifelong: neurodegeneration, intractable epilepsy, progressive neuromuscular disease, devastating metabolic/mitochondrial disorders. You deliver hard diagnoses, manage conditions you can't cure, and walk with families for years, sometimes through a child's decline. This is the honest core of the field and the thing to interrogate in yourself before committing. The counterweights are real: the depth of those years-long family relationships, quality-of-life gains even without cure, and, increasingly, a growing number of conditions that can now actually be treated.19

Career longevity. Generally good, because the outpatient, cognitive nature of the work sustains long careers and reduced-clinical and academic pathways exist. The main threats are cumulative emotional toll and administrative burden (not physical demand), plus call load in understaffed settings. Common longevity strategies: subspecializing (epilepsy, headache), going outpatient-heavy, or leaning into research, and the gene-therapy era has re-energized many veterans.19

Who's in the field (demographics)

  • Women: child neurology is a majority-women specialty. Women are 64.9% of child neurology residents in AY2024-25, against 50.2% across adult neurology in the same census, and 56% of full-time child neurology faculty are women (FREIDA).721 ⟳
  • DO: 13.7% of 2026 matches, after 17.3% in 2025 and 12.4% in 2024, so a real entry point that moves year to year rather than one that is rising.8910 ⟳
  • IMG: 18.5% of 2026 matches, up from 17.8% in 2025 and 11.9% in 2024; neurology broadly is considered IMG-friendly, and child neurology's ~1:1 applicant-to-position environment reinforces it.8910 ⟳
  • Race/ethnicity & URiM: no child-neurology figure is published as a headline number. Neurology broadly is documented as having low URiM representation, with Black and Hispanic residents each well under population share. The child-neurology row sits in AAMC Report on Residents Table B7 (AY 2023-24) and has to be read off there directly.22

Culture, personality & the online stereotypes

Who gravitates here: people who love kids and are pulled by the diagnostic complexity of the developing nervous system (a moving target adult neurology lacks); puzzle-solvers comfortable with rare disease, ambiguity, and conditions without clean answers; those who want long-term, multi-year relationships with children and families over episodic care; mission-driven, patient, empathetic temperaments with high tolerance for chronic disease and emotional durability; and, increasingly, people excited by neurogenetics and precision and gene therapy, the science-forward frontier of the field. As always, plenty of people in the field do not fit any single mold.1923

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The saddest / most heartbreaking specialty." Reality: real heartbreak exists, but the label flattens the field to its worst days and erases the everyday wins: seizure freedom, a walking SMA baby, a family finally getting a diagnosis after years. Most of a typical clinic (headache, responsive epilepsy, tics, developmental follow-up) is not tragic.
  • "Brilliant but depressing." Reality: the "brilliant" half reflects genuine respect for the intellectual rigor; the "depressing" half is an outsider's projection that ignores how meaning and growing treatability sustain the people who do the work.
  • "Underpaid for the training." Partly fair: the ~5-year track is among the longest pediatric routes and pay lands closer to peds than to procedural fields, which is a legitimate gripe. But total comp is often above the peds baseline, and the "starving" framing overlooks strong job security, negotiating leverage, and loan-repayment eligibility.
  • The key correction to all of the above: the field is becoming more treatable, fast. Gene- and molecular-targeted therapies, with SMA the flagship through nusinersen, onasemnogene abeparvovec, and risdiplam, have turned once-uniformly-fatal diagnoses into managed conditions. The "hopeless specialty" narrative is increasingly out of date, and it's actively reshaping the culture toward optimism.19

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums the picture is consistent. People describe it as one of the most intellectually rewarding and mission-driven paths in medicine, with unusually devoted practitioners and unmatched diagnostic variety. A recurring theme is extraordinary meaning offset by emotional cost, and people warn applicants to be honest about their capacity to tolerate chronic and degenerative disease. The most frequent lament is that pay lags the training length and doesn't match adult neurology or procedural fields, framed as the main deterrent for otherwise-interested students. There's strong consensus that demand is enormous, you can practice almost anywhere and name your terms, and employment worry is near zero. And there's growing excitement that neurogenetics/gene therapy repositions the field as a frontier rather than a palliative backwater, with experienced voices actively pushing back on the "all sadness" image. Lifestyle is generally viewed as reasonable and more controllable than most acute specialties, with call and EHR burden the main complaints.19

Voices from the field. Paraphrased from public writing, with links to the originals:

  • Shaan R. Mody, a medical student writing for KevinMD, argues the child neurologist shortage (~20% gap) is a policy failure: demand is surging (autism now ~1 in 31 children), families wait 3–8 months, yet the long ~5-year track pays closer to general pediatrics and burnout runs very high, and calls for shorter training pathways, more CHGME funding, and Medicaid reimbursement reform.18
  • A child neurologist writing in Doximity's Op-Med reflects on professional identity and community in child neurology, the rising centrality of genetics, and the value of understanding the adult trajectory of pediatric-onset disease, portraying a field maturing into its own autonomous, tight-knit community.24
  • Medscape's 2023 reporting on the US neurologist shortage documents pediatric new-patient waits of ~5–6 months (among the longest of any specialty), families driving 6+ hours for care, a worsening supply-demand gap, and ~55% neurologist burnout.25
  • The Child Neurology Society and the Annals of the Child Neurology Society, the field's professional home, frame the shortage, geographic maldistribution, and training-pipeline challenges as central, while promoting the specialty's intellectual reward and mission.26

Why people choose it / why people leave

Why choose it: among the highest-meaning fields in medicine, since you can change the trajectory of a child's whole life · deep, years-long relationships with kids and families · fascinating diagnostic work on the developing nervous system with a strong intellectual identity · a field in therapeutic renaissance where gene/molecular therapies are making the previously untreatable treatable · massive unmet demand → job security, geographic freedom, and loan-repayment leverage · a reasonable, largely daytime lifestyle for such a specialized field.

Why leave or avoid it: the emotional toll of severe, degenerative, and genetic disease can be heavy and cumulative (compassion fatigue, grief accumulation) · ~5-year training for compensation closer to pediatrics than to adult neurology or procedural specialties · high burnout, driven partly by overbooked clinics and staffing shortages · call around status epilepticus and NICU/PICU consults, plus heavy EHR/prior-authorization burden · many conditions remain incurable, so you must be at peace managing rather than fixing.

Best fit if: you love both children and the neuroscience/diagnostic puzzle of the brain · you want continuity and long-term relationships over episodic care · you're emotionally durable and tolerant of chronic disease and uncertainty · you're mission-driven and motivated by impact more than by top-tier pay · you're energized by genetics and the treat-the-untreatable frontier.

Not for you if: you need high procedural income or the shortest path to attending pay · you'd struggle to carry the emotional weight of caring for very sick or dying children · you want fully shift-based work with no continuity or no call · you dislike ambiguity, rare disease, or slow/uncertain diagnostic arcs.

The FLI angle — Child Neurology for first-gen, low-income & immigrant students

Where child neurology fits FLI realities well:

  • An accessible match. Child neurology has historically had a high match rate with unfilled positions most years, and it does not demand the sky-high board scores or research pedigree of the most competitive fields, so a solid, well-rounded applicant has a realistic shot. Interest and competitiveness are rising, but it remains far more attainable than derm/plastics/ortho.811
  • Severe shortage = leverage. A ~20% national workforce gap and long waitlists mean near-guaranteed employment, geographic flexibility, and real negotiating power, including over your schedule. Underserved and rural areas are desperate for child neurologists, and (unusually) compete with premiums rather than discounts.1727
  • Loan-repayment leverage, unusually strong here. High demand plus abundant qualifying employment (children's hospitals, academic centers, HPSA/underserved sites, safety-net systems) makes the field well-suited to PSLF, NHSC, and state loan-repayment/service programs. Critically, the NIH Pediatric Research Loan Repayment Program explicitly gives highest priority to pediatric neurologists doing pediatric research. The NIH LRP repays one-fourth of eligible debt per year, up to $50,000 a year, on 2-year renewable contracts, with ACGME fellows capped at $20k a year. This is a direct, field-specific offset to the modest salary.2829
  • Serve-your-community fit. For FLI students who want to serve the communities they came from, the shortage means the need is greatest exactly where representation is thinnest, a clean match between mission and market.17

Risks to name honestly:

  • Long-ish training for peds-adjacent pay. ~5 years to attending, then compensation that lands closer to pediatrics, roughly the mid-$200ks in AMN's placement framing up to ~$335k median in SalaryDr's, depending on survey, setting, and region, which is a slower, lower payoff on debt than procedural fields. If you need income fast, this is the real tradeoff.141518
  • Emotional toll is not free. Caring for severely or terminally ill children is heavy; without support it accelerates burnout and can undercut the long-career advantage. FLI students carrying outside family responsibilities should be honest about their capacity to absorb pediatric grief over a career.19

Bottom line: strong demand, near-total job security and an unusually good loan-repayment fit make child neurology a genuinely FLI-friendly career. It is one of the cleaner matches between "serve my community" and "the market needs me there." The friction is the length of training relative to the eventual paycheck, so it rewards students motivated by mission and stability over maximum income.

Subspecialties & fellowships

None are required to practice; most add 1–2 years and many are academic-concentrated. Subspecialists generally earn at or modestly above the general child-neuro median (offset partly by the academic pay discount).302

  • Epilepsy / Clinical Neurophysiology (EEG). Seizure management, EEG and long-term/continuous monitoring (EMU, cEEG), and epilepsy-surgery work-up; the largest and most established track, with EEG/EMU reads adding procedural/technical revenue.
  • Neuromuscular medicine / EMG. Muscular dystrophies, SMA, neuropathies; nerve conduction studies and, increasingly, gene and molecular therapies, central to the gene-therapy revolution and a rising-demand niche.
  • Neonatal & fetal neurology. Neurologic care of newborns and premature infants (seizures, HIE, brain injury, prenatal counseling); heavy NICU footprint.
  • Neurocritical care (pediatric). Acute/emergent neurologic disease in the PICU (status epilepticus, brain injury, elevated ICP, neuromonitoring).
  • Neuro-oncology (pediatric). Brain and spinal cord tumors, co-managed with oncology and neurosurgery.
  • Movement disorders. Tics/Tourette, dystonia, ataxia, and other pediatric movement conditions.
  • Headache medicine. Pediatric migraine and headache; high-volume, largely outpatient, high-satisfaction niche.
  • Neuroimmunology / neuroinflammation. Pediatric MS, MOG/NMO, autoimmune encephalitis, demyelinating disease.
  • Neurogenetics / metabolic (biochemical) neurology. Inborn errors of metabolism, leukodystrophies, mitochondrial and neurodegenerative genetic disease, the diagnostic frontier feeding new gene therapies.
  • Neurodevelopmental disabilities (NDD). A related, separately ABPN-board-certifiable path focused on autism, developmental delay, and intellectual disability.
  • Vascular / pediatric stroke. Childhood stroke, moyamoya, vascular malformations.
  • Sleep medicine. Pediatric sleep disorders, often paired with epilepsy/neurophysiology.

Fun facts

  • Child neurology is its own board-certified specialty rather than a subfellowship of adult neurology, and the ~5-year path deliberately blends pediatrics, adult neurology, and child neurology.34
  • Spinal muscular atrophy (SMA) is the field's poster child for transformation. Once a leading genetic cause of infant death, it's now treatable with a one-time gene therapy (Zolgensma or onasemnogene abeparvovec, ~$2.1 million per dose, FDA-approved May 2019) plus antisense (Spinraza or nusinersen, ~$125,000 per dose) and oral (risdiplam) drugs, and babies who once died now walk.3132
  • Newborn screening for SMA, now in all or most states, means child neurologists, and especially neuromuscular subspecialists, are central to time-sensitive, multimillion-dollar treatment decisions, driving multidisciplinary program growth.31
  • Pediatric neurology new-patient waits average ~5–6 months, among the longest in all of medicine, and some families drive 6+ hours to see a specialist.25
  • 78% of pediatric neurologists work in urban settings. This is a maldistribution as much as a shortage; in states like Wyoming the nearest pediatric neurologist can be a 4-hour drive away.17
  • Autism prevalence has climbed to ~1 in 31 US children, a major driver of surging demand on an already thin workforce.18
  • Genetics has become so central that many child neurologists now function as part-time geneticists, and sequencing, variant interpretation, and precision therapy are increasingly routine.19
  • The US child-neurologist supply is estimated to be at least ~20% below national need, and the total workforce is small (~1,290 CNS members + residents in one CNS/AAN analysis).1727

Sources

Footnotes

  1. Child neurology practice shape, scope, day-to-day, and call (dual outpatient/inpatient identity; epilepsy/NICU emergencies; phone-heavy call). Research synthesis: Child Neurology — Lifestyle, Wellbeing, Culture (compiled 2026); SalaryDr, https://www.salarydr.com/specialty/child-neurology (2026). SalaryDr panel size: n=23. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4

  2. Subspecialty/procedural profile (EEG/EMU, epilepsy surgery, gene therapy administration) and the academic-concentration of subspecialty work. Practical Neurology, "Filling the Gap in Pediatric Neurology," https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/; Weill Cornell child-neurology faculty postings, https://pediatrics.weill.cornell.edu/about-us/career-opportunities/assistant-or-associate-professor-pediatric-epilepsy-child-neurology. ↩ ↩2

  3. 5-year pathway structure (2 yr peds + 3 yr child neuro incl. ~12 mo adult neuro; four 5th-year options) and ABPN 60-month requirement. ABPN, "Neurology with Special Qualification in Child Neurology" (2025), https://abpn.org/become-certified/taking-a-specialty-exam/neurology-with-special-qualification-in-child-neurology/. ↩ ↩2 ↩3

  4. ABPN board pathway and structure. ABPN (2025), https://abpn.org/become-certified/taking-a-specialty-exam/neurology-with-special-qualification-in-child-neurology/. ↩ ↩2 ↩3 ↩4

  5. Match entry routes (combined/reserved, categorical + prelim peds, separate lists) and research track. Council of Pediatric Subspecialties (COPS), "Neurology" subspecialty description (current/2025), https://www.pedsubs.org/about-cops/subspecialty-descriptions/neurology/. ↩

  6. Dual ABP (American Board of Pediatrics) certification via ≥2 accredited peds years. American Board of Pediatrics, "Pediatrics-Neurology and Pediatrics-Neurodevelopmental Disabilities" (2026), https://www.abp.org/pediatrics/pediatrics-neurology-or-neurodevelopmental-disabilities. The board states that an applicant who completes at least two years of accredited training in general comprehensive pediatrics, plus the training required for neurology certification with special qualification in child neurology, fulfills the training requirements of both boards. ↩

  7. Program footprint and resident count: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, which gives child neurology 83 programs and 498 active residents, 323 of them women (64.9%), https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. The 56% female full-time faculty figure is AMA FREIDA, "Child Neurology" (accessed 2026), https://freida.ama-assn.org/specialty/child-neurology. Corrected 2026-08-17: this bullet printed "~83 programs; ~595 active residents; average ~7.9 residents per program," three numbers that cannot hold together: 595 across 83 programs is 7.2, and 7.9 across 83 would be 656. The ACGME book, already cited here, counts 498 residents across those same 83 programs, which is 6.0 each. The 595 and the 7.9 were attributed to FREIDA, whose figures are self-reported by programs responding to its survey rather than counted from the full census. The ACGME pair is the independently checkable one and is what the bullet now carries. ↩ ↩2

  8. NRMP, Results and Data: 2025 Main Residency Match (2025): child neurology 78 programs, 195 positions, 185 filled (94.9%); filled mix US MD ~63.8%, DO 17.3%, IMG 17.8%; 136 US-MD seniors ranked it. https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  9. NRMP, Results and Data: 2024 Main Residency Match (2024): child neurology 79 programs, 184 positions, 177 filled (96.2%); filled mix US MD ~75.1%, DO 12.4%, IMG 11.9%. https://www.nrmp.org/wp-content/uploads/2024/06/2024-Main-Match-Results-and-Data-Final.pdf ↩ ↩2 ↩3 ↩4

  10. NRMP, Results and Data: 2026 Main Residency Match, Table 2 — child neurology 211 positions offered, 205 filled, 6 unfilled (97.2%); by applicant type 136 U.S. MD seniors, 3 U.S. MD graduates, 27 U.S. DO seniors, 1 U.S. DO graduate, 9 U.S. IMGs and 29 non-U.S. IMGs, which is 67.8% U.S. MD, 13.7% DO and 18.5% IMG of the filled class. The same report's five-year DO-senior series reads 27 (2026), 32 (2025), 22 (2024), 23 (2023), 15 (2022), and positions offered ran 166 in 2022 against 211 in 2026, up about 27%. https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf The fill rate and the growth figure were also relayed by Shaan R. Mody, KevinMD (2026), https://kevinmd.com/2026/07/the-child-neurologist-shortage-is-a-policy-choice.html. Corrected 2026-08-17: the 2026 cycle previously reached this page only through the KevinMD op-ed and only for the fill rate, while the dashboard, the competitiveness section and the demographics section all described DO and IMG access from the 2025 report as "meaningful and rising." NRMP publishes the composition itself, and the DO share fell back to 13.7% in 2026 after 17.3% in 2025, so it is volatile in a 12–17% band rather than rising. The IMG half of the claim holds. Swept 2026-08-17: DO 13.7% and IMG 18.5%, both over the 205 positions filled, against all-PGY-1 baselines of 21.5% DO and 25.2% IMG over 38,354 filled positions in the same table. Child neurology sits below the average on both counts, so the competitiveness row's "IMG/DO-accessible" and the accessibility row's "meaningful" were bare comparatives the figures contradict; both rows now name the baseline. The low competitiveness, which is about how many seats go unfilled rather than who fills them, is unaffected. Child neurology enters through its own categorical residency rather than through pediatrics, so the pediatrics gate's 21.1%/30.4% does not apply here. ↩ ↩2 ↩3 ↩4

  11. "Low" competitiveness for US seniors; IMG-friendly at ~1:1 applicant-to-position. ProspectiveDoctor, "How Competitive is a Child Neurology Residency? (2025)," https://www.prospectivedoctor.com/how-competitive-is-a-child-neurology-residency/. ↩ ↩2

  12. Matched-applicant academics (2022 cycle, from NRMP Charting Outcomes as summarized): mean Step 2 CK ~247; >21% held a PhD. yousmle, "Is Child Neurology Competitive?" (2022/23 data), https://www.yousmle.com/is-child-neurology-competitive/. The underlying figures are NRMP's. ↩

  13. Doximity 2025 Physician Compensation Report (2024 data): Adult Neurology $360,519 · Child Neurology $289,738 · General Pediatrics $265,230; "systemic lag in pay for pediatric specialty care." https://www.doximity.com/reports/physician-compensation-report/2025 ↩ ↩2 ↩3 ↩4

  14. SalaryDr, "U.S. Child Neurology Physician Salary" (2026): median $335,000; mean $329,273; 10th $260k / 25th $279,790 / 75th $345k / 90th $395k; range $260k–$500k; base $270,839; 96% bonus (median $65k); early $305,229 vs 10+ yr $347,769; hospital-employed $340,486 vs academic $308,714; city averages; ~45 hrs/wk; ~4.0/5 satisfaction; ~87% would choose again. https://www.salarydr.com/specialty/child-neurology SalaryDr panel size: n=23. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  15. AMN Healthcare, Neurologist Salary Report 2025: pediatric/child neurology $225,000–$250,000, starting ~$180,000; adult neuro avg $244,000; neuro-oncology $341,000; MS $267,000; movement disorders $240,000. https://www.amnhealthcare.com/blog/physician/perm/neurologist-salary-report-2025/ ↩ ↩2 ↩3

  16. MGMA 2025 Provider Compensation and Productivity Data Report (2024 data) — pediatric neurology medians paywalled, not extracted. https://www.mgma.com/2025-provider-compensation ↩

  17. Urban concentration (78%), rural access gaps, and shortage-driven recruitment premiums/telehealth. Practical Neurology, "Filling the Gap in Pediatric Neurology" (CNS/AAN workforce data; ~1,290 members; 45-day waits), https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/. ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  18. Shaan R. Mody, "The child neurologist shortage is a policy choice," KevinMD (2026): ~20% shortage; 3–8 month waits; pay ~$225–250K framing; autism ~1 in 31; reimbursement-reform argument. https://kevinmd.com/2026/07/the-child-neurologist-shortage-is-a-policy-choice.html On the >80% burnout figure: the article states that more than 86 percent of pediatric neurologists reported symptoms of burnout and names no survey, instrument or year behind it, and the piece is an opinion column by a second-year medical student. It is the only child-neurology-specific burnout figure in circulation, which is why it stays on the page, and it carries no measurement provenance, which is why it is labeled commentary rather than data. Corrected 2026-08-17: the dashboard row presented it as a burnout percentage alongside the parent-field survey figure, with no signal that it is unsourced. ↩ ↩2 ↩3 ↩4 ↩5

  19. Lifestyle, wellbeing, emotional weight, culture, online sentiment, and stereotypes. Research synthesis: Child Neurology — Lifestyle, Wellbeing, Culture & FLI Relevance (compiled mid-2026), drawing on SalaryDr (2026), Medscape, and paraphrased forum sentiment (r/Neurology, r/pediatrics, r/medicalschool, SDN — no quotes reproduced). SalaryDr does not publish a panel size for the page cited here (its blog and career-guide pages omit the n that its per-specialty pages carry), so the panel-size caveat this site attaches to a self-selected panel cannot be quantified for this figure. Treat it as a self-selected panel of unknown size. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12

  20. Parent-field burnout, 44%. Medscape Physician Burnout & Depression Report 2024 (2023 data, 9,226 physicians) puts neurology at 44%, seventh of the ten lowest-burnout specialties it names, against a 49% all-physician average. Medscape is paywalled, so the row is read through a relay: Healthgrades Pro, The Most and Least Burned Out Physicians by Specialty, https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty. On the instrument: the AMA's 2025 Organizational Biopsy is free and primary and is preferred wherever it publishes a row, and it publishes no neurology row, so Medscape is the correct instrument here. Its all-physician baseline of 49% sits seven points above the AMA's 41.9% and the two never belong in the same sentence. ↩

  21. Women residents, 64.9% in child neurology and 50.2% in adult neurology, both AY2024-25: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. The 56% female-faculty figure is AMA FREIDA (2026), https://freida.ama-assn.org/specialty/child-neurology. Corrected 2026-08-13: this page carried "~60% of residents (est.)," an estimate rather than a count, and set it against 50.7% for adult neurology from the AMA/AAMC National GME Census (AMA, "Physician specialties with the biggest gender imbalances," 2025, https://www.ama-assn.org/medical-students/preparing-residency/these-physician-specialties-have-biggest-gender-imbalances). Both figures now come from the ACGME book, because the two censuses use different denominators and quoting one beside the other reads as a single dataset when it is not. ↩

  22. Race/ethnicity and URiM — no published child-neurology figure; neurology broadly runs low on URiM representation. AAMC Report on Residents Table B7 (AY 2023-24), https://www.aamc.org/data-reports/students-residents/data/report-residents/2024/table-b7-residents-race-ethnicity-and-specialty. ↩

  23. Who gravitates / temperament. Indiana University School of Medicine, "Child Neurology" specialty preparation guide, https://medicine.iu.edu/mse/support/career-development/specialty-preparation-guide/child-neurology. ↩

  24. Donald L. Gilbert, MD, MS — Doximity Op-Med, on child-neurology identity, community, and the rising role of genetics. https://opmed.doximity.com/articles/why-do-child-neurologists-go-to-the-annual-american-academy-of-neurology-meetings ↩

  25. Medscape, "Is the US Neurologist Shortage Insurmountable?" (2023): pediatric ~5–6 month waits; families driving 6+ hours; worsening supply-demand gap. https://www.medscape.com/viewarticle/996637 This article also reported neurologist burnout at ~55%; that is Medscape's 2023 edition, and the current edition puts neurology eleven points lower. The parent-field figure the page uses is in 20. Corrected 2026-08-17: the ~55% previously ran in the dashboard, the wellbeing lede and the wellbeing figure caption as the current parent-field rate. ↩ ↩2

  26. Child Neurology Society / Annals of the Child Neurology Society — workforce shortage and mission framing. https://www.childneurologysociety.org/; Annals of the CNS, "Child Neurology Workforce Shortage," https://www.ovid.com/journals/acns/fulltext/10.1002/cns3.70011~child-neurology-workforce-shortage-challenges-and. ↩

  27. US child-neurologist supply ~≥20% below need; small total workforce. COPS, "Neurology" (current), https://www.pedsubs.org/about-cops/subspecialty-descriptions/neurology/. ↩ ↩2

  28. NIH Loan Repayment Program — repays one-fourth of eligible debt per year up to $50,000/year (fellows capped $20k/yr); Pediatric Research LRP gives highest priority to pediatric neurologists. NIH LRP Award, https://grants.nih.gov/funding/funding-categories/lrp/award; NINDS LRP, https://www.ninds.nih.gov/funding/training-career-development/postdoctoral-fellows/loan-repayment-program; NIH Notice NOT-OD-13-083, https://grants.nih.gov/grants/guide/notice-files/NOT-OD-13-083.html. ↩

  29. HRSA National Health Service Corps Loan Repayment (HPSA/underserved service). https://nhsc.hrsa.gov/loan-repayment. Whether a given child-neurology post qualifies turns on the site's NHSC approval status. ↩

  30. Fellowships/subspecialties open to child neurologists (epilepsy, neuromuscular, NDD, etc.). COPS "Neurology," https://www.pedsubs.org/about-cops/subspecialty-descriptions/neurology/; ABPN Neurodevelopmental Disabilities subspecialty, https://www.abpn.com/become-certified/taking-a-subspecialty-exam/neurodevelopmental-disabilities/. ↩

  31. SMA gene therapy and newborn-screening context: Zolgensma ~$2.1M/dose (FDA-approved May 2019); Spinraza ~$125,000/dose. Cincinnati Children's, "SMA Gene Therapy," https://www.cincinnatichildrens.org/professional/subspecialist-news/neurology-neurosurgery/sma-gene-therapy. ↩ ↩2

  32. FDA, "FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy" (2019). https://www.fda.gov/news-events/press-announcements/fda-approves-innovative-gene-therapy-treat-pediatric-patients-spinal-muscular-atrophy-rare-disease ↩

Researched with AI assistance and reviewed by hand. How this site is made